The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity
about
TIM-family proteins promote infection of multiple enveloped viruses through virion-associated phosphatidylserineN-Acetylglucosamine Inhibits T-helper 1 (Th1)/T-helper 17 (Th17) Cell Responses and Treats Experimental Autoimmune EncephalomyelitisProinflammatory stimuli induce galectin-9 in human mesenchymal stromal cells to suppress T-cell proliferationA crucial role for Kupffer cell-derived galectin-9 in regulation of T cell immunity in hepatitis C infectionProfiling Lgals9 splice variant expression at the fetal-maternal interface: implications in normal and pathological human pregnancyGalectin-9 binding to cell surface protein disulfide isomerase regulates the redox environment to enhance T-cell migration and HIV entryThe Galectin-9/Tim-3 pathway is involved in the regulation of NK cell function at the maternal-fetal interface in early pregnancyGalectin-9 functionally impairs natural killer cells in humans and miceUp-regulation of galectin-9 induces cell migration in human dendritic cells infected with dengue virusGalectin-9 enhances cytokine secretion, but suppresses survival and degranulation, in human mast cell lineLacritin and the tear proteome as natural replacement therapy for dry eyeImmunoglobulin A (IgA) is a natural ligand of hepatitis A virus cellular receptor 1 (HAVCR1), and the association of IgA with HAVCR1 enhances virus-receptor interactionsDysregulated T cell expression of TIM3 in multiple sclerosisEarly Events in Chikungunya Virus Infection-From Virus Cell Binding to Membrane FusionImmunobiology of hepatocarcinogenesis: Ways to go or almost there?Immune checkpoint blockade therapy for bladder cancer treatmentTIM-3 Regulates Distinct Functions in MacrophagesHost nucleotide polymorphism in hepatitis B virus-associated hepatocellular carcinomaImmune Checkpoint Modulators: An Emerging Antiglioma ArmamentariumRole of Tim-3 in hepatitis B virus infection: An overviewNovel cancer antigens for personalized immunotherapies: latest evidence and clinical potentialDisrupted regulatory T cell homeostasis in inflammatory bowel diseasesImmune Checkpoint Modulation in Colorectal Cancer: What's New and What to ExpectMelanoma: oncogenic drivers and the immune systemAdvances in immunotherapy for treatment of lung cancerBeyond CTLA-4 and PD-1, the Generation Z of Negative Checkpoint RegulatorsGalectin-Binding O-Glycosylations as Regulators of MalignancyImmunotherapy in the treatment of non-small cell lung cancerGalectins and their ligands: negative regulators of anti-tumor immunityGalectin-9/TIM-3 interaction regulates virus-specific primary and memory CD8 T cell responseStructures of T Cell Immunoglobulin Mucin Protein 4 Show a Metal-Ion-Dependent Ligand Binding Site where Phosphatidylserine BindsT Cell/Transmembrane, Ig, and Mucin-3 Allelic Variants Differentially Recognize Phosphatidylserine and Mediate Phagocytosis of Apoptotic CellsX-ray Structures of Human Galectin-9 C-terminal Domain in Complexes with a Biantennary Oligosaccharide and SialyllactoseStructure of full-length Toxascaris leonina galectin with two carbohydrate-recognition domainsAdaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints.The blockade of immune checkpoints in cancer immunotherapyResearch Advance in Intestinal Mucosal Barrier and Pathogenesis of Crohn's DiseaseSpecific CD8(+) T cell response immunotherapy for hepatocellular carcinoma and viral hepatitisVitamin D Actions on CD4(+) T Cells in Autoimmune DiseaseGalectins: Double-edged Swords in the Cross-roads of Pregnancy Complications and Female Reproductive Tract Inflammation and Neoplasia
P2860
Q21131381-88C1DE8C-2EAF-4C57-A6B6-79D6CD71A428Q22248070-BA6B78C7-09C6-47AB-88E3-3975A28A78A4Q24297200-EE38B6AD-4BE1-445E-99C0-6EAA2E06FDB4Q24301928-0C924790-67E9-4D12-9131-B5588A707162Q24306204-1D9896C1-DC1C-4B5F-8F9A-03BF6B289184Q24306482-A58C41C8-CEB5-4867-BBD5-2212F5771D45Q24313559-C57DDC8A-588E-4376-9DF5-25BD9A072DB5Q24317152-A01295F9-4CA7-4C49-A032-50A1A0376054Q24321941-C2B5C297-E3A4-4298-9493-EC5DCCEFA2F7Q24323267-10CFE879-7750-4FC8-BC52-FCDCC6C1D014Q24594010-33442060-BD6A-4551-8980-8826F545DA81Q24672280-2F2C77FE-6D22-489A-A121-F9AEF9D56106Q24676780-017F2F68-5339-404A-9295-9A876F6C192CQ24701760-BE892709-E2A3-4B39-B3CE-3AEE59D9193FQ26738293-82C0C8F7-8FDB-4044-9BB3-08CEDCB1DA4FQ26744139-CB1EF074-CDE4-49B2-BA18-043A49979597Q26744557-1904F459-6BA6-44A9-B5C2-2B2D0177BDADQ26750792-73A86897-B1D4-431C-98FF-C6447B0CC1D4Q26765459-F1514602-A65D-4486-A727-2C9BBEE01C46Q26768530-CCC631E9-AB18-483B-8D7E-DF56AC2F5A5BQ26769884-9C1DD4D6-73ED-4093-827D-AEE98339BC9AQ26774590-215A4A84-EB0F-4AAE-BBA2-896F665825B6Q26775578-6CE5CB8D-40D7-4A19-A971-09B266DDBE5DQ26775598-F40B67E4-CA38-4216-BC7E-8A3E06CEA7FBQ26778790-68F9FA0D-71A6-4C28-AAF1-B72BA43B669EQ26782799-A947178B-1D61-4878-B2A4-600029B3354AQ26801724-A82831AB-3730-4DF4-8201-5A2C9528955CQ27000382-273EBDC2-A522-4A6C-AB1D-45288D0FE5F0Q27024580-75C64CEE-976C-49F1-BFDD-F5A88C7F80A7Q27314881-108F00C1-6736-4E14-B700-D263ACE83071Q27649330-D3017083-EF41-484B-AA8F-E00DF64AC165Q27659032-099641A0-8556-40A6-9A65-FB1AF21FA9D7Q27664638-157ABAEC-0449-4E33-AF37-09AF737CCECAQ27683930-0105246F-5619-4F26-8B3C-E9F7F623CA43Q27853339-DDC3BD1A-EB6C-4FD1-8454-FCF7CBED795EQ27860852-BF43B366-016F-4397-B859-C1ECADF65C02Q28066444-859F671C-0DFA-4B6E-B166-CE52CE592280Q28074434-855E4BC4-1D5D-436B-85A5-F5D74DB3B5CBQ28081150-90AB967C-72DF-4DE9-BBBB-0453543A67CDQ28081459-2F7DEBA7-0F62-43A0-B415-EA8567C9678A
P2860
The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity
@ast
The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity
@en
The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity
@nl
type
label
The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity
@ast
The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity
@en
The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity
@nl
prefLabel
The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity
@ast
The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity
@en
The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity
@nl
P2093
P3181
P356
P1433
P1476
The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity
@en
P2093
Ana C Anderson
Anna Schubart
Huabao Xiong
Jaime Imitola
Samia J Khoury
Terry B Strom
Vijay K Kuchroo
Xin Xiao Zheng
P304
P3181
P356
10.1038/NI1271
P407
P577
2005-12-01T00:00:00Z